Disease relevance of Embolization, Therapeutic

• We describe two patients, each with an arteriovenous malformation, who had therapeutic embolization with radiolabeled Ivalon particles, one resulting in reflux migration and the other resulting in inadvertent pulmonary embolism [1].
• PURPOSE: To determine long-term durability and efficacy of pulmonary arteriovenous malformation (PAVM) embolotherapy using detachable gold valve latex (GVB) and silicone balloons (DSB) [2].
• Isobutyl-2-cyanoacrylate pulmonary emboli associated with occlusive embolotherapy of cerebral arteriovenous malformations [3].
• Absolute ethanol was used to treat 20 patients with symptomatic vascular malformations (SVMs) (ie, venous malformations, arteriovenous malformations, and congenital and posttraumatic arteriovenous fistulas) in whom previous surgery or standard embolotherapy had failed or who were not candidates for surgery [4].
• Absolute ethanol embolotherapy for hemangioma with Kasabach-Merritt syndrome [5].

High impact information on Embolization, Therapeutic

• Interventional radiology (pulmonary angiography, coil embolotherapy, and TIPS) in patients with HPS seems to provide both diagnostic data and therapeutic results of clinical importance [6].
• Selective arteriography was performed in all patients; transcatheter treatment was performed by means of embolotherapy or selective vasopressin infusion [7].
• Twenty-four patients underwent embolotherapy, and 12 were treated with nontranscatheter therapy such as surgery, Sengstaken-Blakemore tube placement, endoscopic submucosal injection of epinephrine, or supportive medical therapy [8].
• Symptomatic vascular malformations: ethanol embolotherapy [9].
• Of the six patients who were considered unsuitable for embolotherapy, one patient died of hepatocellular carcinoma, two had significant progression of symptoms, and the remaining three patients' symptomatology was unchanged [10].

Chemical compound and disease context of Embolization, Therapeutic

• Histopathological follow-up study of 66 cerebral arteriovenous malformations after therapeutic embolization with polyvinyl alcohol [11].
• Three patients had cerebral arteriovenous malformations (AVM) treated by occlusive embolotherapy using isobutyl-2-cyanoacrylate (IBC) [3].
• CONCLUSION: Though the full effects of methohexital in the cerebral circulation remain to be elucidated, existing reports suggest it is a safe provocative agent for use prior to embolotherapy for brain arteriovenous malformations [12].
• In cases of life-threatening or persistent hemorrhage, once a bleeding source is identified, the interventional radiologist may offer percutaneous transcatheter therapy with selective intraarterial vasopressin infusion or embolotherapy [13].

Biological context of Embolization, Therapeutic

• Embolotherapy was eventually abandoned in favor of catheter-directed vasoconstriction (i.e., vasopressin infusion) [14].

Anatomical context of Embolization, Therapeutic

• Lidocaine injection into external carotid branches: provocative test to preserve cranial nerve function in therapeutic embolization [15].
• The AVM removed 10 days after PVA embolotherapy showed mural and perivascular necrosis with infiltration by polymorphonuclear leukocytes [16].
• Successful embolotherapy was performed by selective injection of polyvinyl alcohol particles into the culprit bronchial artery [17].

Associations of Embolization, Therapeutic with chemical compounds

• Continuous and dynamic monitoring of injected radiolabeled Ivalon particles is made possible by viewing the persistence scope of a portable gamma camera whose head is positioned over the patient undergoing therapeutic embolization [1].
• These patients had sufficient symptoms to justify therapeutic embolization with polyvinyl alcohol [18].
• There is controversy as to the possible toxic effects of isobutyl-2-cyanoacrylate (bucrylate) when this substance is used for purposes of therapeutic embolization [19].
• Intraarterial use of sodium methohexital for provocative testing during brain embolotherapy [12].
• In one patient, Octreoscan 111 was used to evaluate the efficacy of therapeutic embolization [20].

Gene context of Embolization, Therapeutic

• Use of a combined CT-angiography system for demonstration of correlative anatomy during embolotherapy for hepatocellular carcinoma [21].
• CONCLUSIONS: Coil embolotherapy is highly efficacious, with no statistically significant difference between platinum and stainless-steel coils [22].
• Glutaraldehyde cross-linked collagen (GAX): a new material for therapeutic embolization [23].
• Aneurysmal bone cysts: imaging findings and embolotherapy [24].
• Recognition of Chiari's triad: mid-thoracic pain, sentinel arterial haemorrhage, and final exsanguination after a symptom-free interval, and therapeutic embolization as a mode of therapy, are discussed [25].

Analytical, diagnostic and therapeutic context of Embolization, Therapeutic

• Five patients were treated by vasopressin infusion, balloon tamponade, or therapeutic embolization [26].

References